Table 4. Purposes of the use of medicinal plants reported in the medical records of pediatric sickle cell patients at the Hematology Outpatient Clinic of the Blood Center of Palmas (TO). Data were collected from June 2022 to May 2023.
| Use (medical records) | n* | % |
|---|---|---|
| Influenza | 96 | 42.7 |
| Pain | 20 | 8.9 |
| COVID-19 prevention | 17 | 7.6 |
| Influenza prevention | 13 | 5.8 |
| Gastrointestinal symptoms | 12 | 5.3 |
| Abdominal pain | 12 | 5.3 |
| Jaundice | 10 | 4.4 |
| COVID-19 | 10 | 4.4 |
| Fever | 8 | 3.6 |
| Sickle cell disease | 6 | 2.7 |
| Insomnia | 4 | 1.8 |
| Calming and anti-anxiety | 4 | 1.8 |
| Immunity | 3 | 1.3 |
| Blood purification | 2 | 0.9 |
| Dengue fever | 2 | 0.9 |
| Anemia | 1 | 0.4 |
| Urinary symptoms | 1 | 0.4 |
| 225 | 100.0 |
*Number of medical records citing this use.